Glowing Opportunities: Exploring Radioisotope Clinical Applications

Currently the two largest indications for theranostics is for treatment of advanced metastatic prostate cancer and for treating neuroendocrine cancers.

There is currently promising research into using theranostics for other difficult to treat cancers for example brain cancers, pancreatic and others.